ALF Again Argues That “Drug Price Negotiation Program” Is Unconstitutional
The Inflation Reduction Act’s highly politicized, misleadingly named, “Drug Price Negotiation Program,” 42 U.S.C. § 1320f et seq., is a form of government-imposed price control. Under the Program, the Centers for Medicare & Medicaid Services (CMS) selects certain “negotiation-eligible” brand-name drugs. Following a supposed “negotiation” and “agreement” with its manufacturer, each such drug can be sold within […]
ALF Again Argues That “Drug Price Negotiation Program” Is Unconstitutional Read More »